Mechanisms Underlying the Opposing Effects of P2Y Receptors on the Cell Cycle

References

• Erb L, Liao Z, Seye CI, Weisman GA. P2 receptors, intracellular signaling. Pflugers Arch 2006, 452, 552–562.
   Google Scholar
• Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, Sharpe GR, Gallagher JA. Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 1999, 127, 1680–1686.
   Google Scholar
• Agresti C, Meomartini ME, Amadio S, Ambrosini E, Volonté C, Aloisi F, Visentin S. ATP regulates oligodendrocyte progenitor migration, proliferation, and differentiation, involvement of metabotropic P2 receptors. Brain Res Brain Res Rev 2005, 48, 157–165.
   Google Scholar
• Neary JT, Kang Y, Shi YF, Tran MD, Wanner IB. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions. Novartis Found Symp 2006, 276, 131–143.
   Google Scholar
• Arthur DB, Akassoglou K, Insel PA. P2Y2 and TrkA receptors interact with Src family kinase for neuronal differentiation. Biochem Biophys Res Commun 2006, 347, 678–682.
   Google Scholar
• Sak K, Boeynaems JM, Everaus H. Involvement of P2Y receptors in the differentiation of haematopoietic cells. J Leukoc Bio 2003, 73, 442–447.
   Google Scholar
• Sugiyama T, Kawamura H, Yamanishi S, Kobayashi M, Katsumura K, Puro, DG. Regulation of P2X7-induced pore formation and cell death in pericyte-containing retinal microvessels. Am J Physiol Cell Physiol 2005, 288, C568–C576.
   Google Scholar
• Turner CM, King BF, Srai KS, Unwin RJ. Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Renal Physiol 2007, 292, F15–F25.
   Google Scholar
• Schäfer R, Hartig R, Sedehizade F, Welte T, Reiser G. Adenine nucleotides inhibit proliferation of the human lung adenocarcinoma cell line LXF-289 by activation of nuclear factor κB1 and mitogen-activated protein kinase pathways. FEBS J 2006, 273, 3756–3767.
   Google Scholar
• Maaser K, Hopfner M, Kap H, Sutter AP, Barthel B, von Lampe B, Zeitz M, Scherübl H. Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y2-receptors. Br J Cancer 2002, 86, 636–644.
   Google Scholar
• Hopfner M, Maaser K, Barthel B, von Lampe B, Hanski C, Riecken EO, Zeitz M, Scherübl H. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells, involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Colorectal Dis 2001, 16, 154–166.
   Google Scholar
• White N, Ryten M, Clayton E, Butler P, Burnstock G. P2Y purinergic receptors regulate the growth of human melanomas. Cancer Lett 2005, 224, 81–91.
   Google Scholar
• Katzur AC, Koshimizu T, Tomic M, Schultze-Mosgau A, Ortmann O, Stojilkovic SS. Expression and responsiveness of P2Y2 receptors in human endometrial cancer cell lines. J Clin Endocrinol Metab 1999, 84, 4085–4091.
   Google Scholar
• Amedova LK, Gao ZG, Jacobson KA. Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors. Biochem Pharmacol 2006, 72, 1031–1041.
   Google Scholar
• Cavaliere F, Nestola V, Amadio S, D’Ambrosi N, Angelini DF, Sancesario G, Bernardi G, Volonté C. The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 2005, 18, 100–109.
   Google Scholar
• Sellers LA, Simon J, Lundahl TS, Cousens DJ, Humphrey PP, Barnard EA. Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem 200l, 276, 16379–16390.
   Google Scholar
• Neary JT, Kang Y, Bu Y, Yu E, Akong K, Peters, CM. Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes, involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J Neurosci 1999, 19, 4211–4220.
   Google Scholar
• Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V. Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATcl and the Ca2+ /calcineurin signaling pathway. EMBO J 2006, 25, 37143724.
   Google Scholar
• Sohm F, Gaiddon C, Antoine M, Boutillier AL, Loeffler JP. The retinoblastoma susceptibility gene product/Sp1 signalling pathway is modulated by Ca2+ /calmodulin kinases II and IV activity. Oncogene 1999, 18, 2762–2769.
   Google Scholar
• Garcia E, Stracher A, Jay D. Calcineurin dephosphorylates the C-terminal region of filamin in an important regulatory site, a possible mechanism for filamin mobilization and cell signaling. Arch Biochem Biophys 2006, 446, 140–150.
   Google Scholar
• Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT, Sun GY, Weisman GA, Gonzalez FA. P2Y receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 2004, 91, 119–132.
   Google Scholar
• Chen L, He HY, Li HM, You JF, Heng WJ, Li Y, Fang WG. ERK1/2 and p38 kinases are important regulators in P2Y receptor-mediated prostate cancer invasion. Zhonghua Yi Xue Za Zhi 2005, 85, 111–114.
   Google Scholar
• White PJ, Webb TE, Boarder MR. Characterization of a Ca2+ response to both UTP and ATP at human P2Y11 receptors, evidence for agonist-specific signaling. Mol Pharmacol 2003, 63, 1356–1363.
   Google Scholar
• Conkright MD, Montminy M. CREB, the unindicted cancer co-conspirator. Trends Cell Biol 2005, 15, 457–459.
   Google Scholar
• Van Kolen K, Slegers H. Atypical PKC is involved in RhoA-dependent mitogenic signaling by the P2Y12 receptor in C6 cells. FEBS J 2006, 273, 1843–1854.
   Google Scholar
• Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA, Collard JG. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 2000, 36, 1269–1274.
   Google Scholar
• Liao Y, Yu D, Hung M. Novel Approaches for Chemosensitization of Breast Cancer Cells: The E1A Story in Breast Cancer sensitivity. Austin, Landes Bioscience and Eurekah, 2003.
   Google Scholar
• Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA, International Union of Pharmacology LVIII: Update on the P2Y G protein-coupled nucleotide receptors: From molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 2006, 58, 281–341.
   Google Scholar
• Wilkin F, Duhant X, Bruyns C, Suarez-Huerta N, Boeynaems JM, Robaye B. The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells. J Immunol 2001, 166, 7172–7177.
   Google Scholar
• Hatanaka H, Takada S, Choi YL, Fujiwara S, Soda M, Enomoto M, Kurashina K, Watanabe H, Yamashita Y, Sugano K, Mano H. Transforming activity of purinergic receptor P2Y, G-protein coupled, 2 revealed by retroviral expression screening. Biochem Biophys Res Commun 2007, 356, 723–726.
   Google Scholar
• Turner CM, King BF, Srai KS, Unwin RJ. Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro. Am J Physiol Renal Physiol 2007, 292, F15–F25.
   Google Scholar
• Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G. Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int 2008, 101, 352–359.
   Google Scholar
• Alvarado-Castillo C, Harden TK, Boyer JL. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDasel and NTPDase2. Mol Pharmacol 2005, 67, 114–122.
   Google Scholar
• Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol 2003, 64, 785–795.
   Google Scholar
• Schäfer R, Sedehizade F, Welte T, Reiser G. ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Physiol Lung Cell Mol Physiol 2003, 285, L376-L385.
   Google Scholar
• Dubey RK, Gillespie DG, Shue H, Jackson EK. A2B, receptors mediate antimito-genesis in vascular smooth muscle cells. Hypertension 2000, 35, 267–272.
   Google Scholar
• Adinolfi E, Callegari MG, Ferrari D, Bolognesi C, Minelli M, Wieckowski MR, Pinton P, Rizzuto R, Di Virgilio F. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol Biol Cell 2005, 16, 3260–3272.
   Google Scholar
• Arthur DB, Georgi S, Akassoglou K, Insel PA. Inhibition of apoptosis by P2Y2 receptor activation, novel pathways for neuronal survival. J Neurosci 2006, 26, 3798–3804.
   Google Scholar
• Liu J, Liao Z, Camden J, Griffin KD, Garrad RC, Santiago-Perez LI, Gonzalez FA, Seye CI, Weisman GA, Erb L. Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J Biol Chem 2004, 279, 8212–8218.
   Google Scholar
• Koga F, Xu W, Karpova TS, McNally JG, Baron R, Neckers L. Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation. Proc Natl Acad Sci USA 2006, 103, 11318–11322.
   Google Scholar
• Chorna NE, Chevres M, Santos-Berrios C, Orellano EA, Erb L, Gonzalez FA. P2Y2 receptors induced cell surface redistribution of αυ integrin is required for activation of ERK 1/2 in U937 cells. J Cell Physiol 2007, 211, 410–422.
   Google Scholar
• Kudirka JC, Panupinthu N, Tesseyman MA, Dixon SJ, Bernier SM. P2Y nucleotide receptor signaling through MAPK/ERK is regulated by extracellular matrix. Involvement of β3 integrins. J Cell Physiol 2007, 213, 54–64.
   Google Scholar
• Suzuki T, Namba K, Tsuga H, Nakata H. Regulation of pharmacology by heterooligomerization between A1 adenosine receptor and P2Y2 receptor. Biochem Biophys Res Commun 2006, 351, 559–565.
   Google Scholar
• D’Ambrosi N, Iafrate M, Saba E, Rosa P, Volonté C. Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems. Biochim Biophys Acta 2007, 1768, 1592–1599.
   Google Scholar
• Coutinho-Silva R, Stahl L, Cheung KK, de Campos NE, de Oliveira Souza C, Ojcius DM, Burnstock G. P2X and P2Y purinergic receptors on human intestinal epithelial carcinoma cells: Effects of extracellular nucleotides on apoptosis and cell proliferation. Am J Physiol Gastrointest Liver Physiol 2005, 288, G1024–G1035.
   Google Scholar
• Marteau F, Le Poul E, Communi D, Communi D, Labouret C, Savi P, Boeynaems JM, Gonzalez NS. Pharmacological characterization of the human P2Y13 receptor. Mol Pharmacol 2003, 64, 104–112.
   Google Scholar
• Kaiser RA, Oxhorn BC, Andrews G, Buxton IL. Functional compartmentation of endothelial P2Y receptor signaling. Circ Res 2002, 91, 292–299.
   Google Scholar
• Communi D, Motte S, Boeynaems JM, Pirotton S. Pharmacological characterization of the human P2Y4 receptor. Eur J Pharmacol 1996, 317, 383–389.
   Google Scholar
• Baker OJ, Camden JM, Ratchford AM, Seye CI, Erb L, Weisman GA. Differential coupling of the P2Y1 receptor to Gα14 and Gαq/11 proteins during the development of the rat salivary gland. Arch Oral Biol 2006, 51, 359–370.
   Google Scholar
• Fam SR, Paquet M, Castleberry AM, Oller H, Lee CJ, Traynelis SF, Smith Y, Yun CC, Hall RA. P2Y1 receptor signaling is controlled by interaction with the PDZ scaffold NHERF-2. Proc Natl Acad Sci USA 2005, 102, 8042–8047.
   Google Scholar
• Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira- dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, Wyss JM, Mecham RP, Blumer KJ. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 2003, 111, 445–452.
   Google Scholar
• Fredholm BB, Assender JW, Irenius E, Kodama N, Saito N. Synergistic effects of adenosine A1 and P2Y receptor stimulation on calcium mobilization and PKC translocation in DDT1 MF-2 cells. Cell Mol Neurobiol 2003, 23, 379–400.
   Google Scholar
• Gerevich Z, Borvendeg SJ, Schroder W, Franke H, Wirkner K, Nörenberg W, Fürst S, Gillen C, Illes P. Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 2004, 24, 797–807.
   Google Scholar
• Kass GE, Orrenius S. Calcium signaling and cytotoxicity. Environ Health Perspect 1999, 107, 25–35.
   Google Scholar
• Rodriguez A, Webster P, Ortego J, Andrews NW. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 1997, 137, 93–104.
   Google Scholar
• Andreyev A, Fiskum G. Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver. Cell Death Differ 1999, 6, 825–832.
   Google Scholar
• Schild L, Keilhoff G, Augustin W, Reiser G, Striggow F. Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria. FASEB J 2001, 15, 565–567.
   Google Scholar
• Kahl CR, Means AR. Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 2003, 24, 719–736.
   Google Scholar
• Lotem J, Kama R, Sachs L. Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc Natl Acad Sci USA 1999, 96, 12016–12020.
   Google Scholar
• Greber UF, Gerace L. Depletion of calcium from the lumen of endoplasmic reticulum reversibly inhibits passive diffusion and signal-mediated transport into the nucleus. J Cell Biol 1995, 128, 5–14.
   Google Scholar
• Dong Z, Bode AM. Dialogue between ERKs and JNKs, friendly or antagonistic? Mol Interv 2003, 3, 306–308.
   Google Scholar
• Dixon CJ, White PJ, Hall JF, Kingston S, Boarder MR. Regulation of human hepatocytes by P2Y receptors, control of glycogen phosphorylase, Ca2+, and mitogen-activated protein kinases. J Pharmacol Exp Ther 2005, 313, 1305–1313.
   Google Scholar
• Shinozaki Y, Koizumi S, Ohno Y, Nagao T, Inoue K. Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes. Glia 2006, 54, 606–618.
   Google Scholar
• Neary JT, Kang Y. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes. J Neurosci Res 2006, 84, 515–524.
   Google Scholar
• Tanoue T, Moriguchi T, Nishida E. Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 1999, 274, 19949–19956.
   Google Scholar
• He HY, Zheng J, Li Y, Heng WJ, Fang WG. SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion. Zhonghua Bing Li Xue Za Zhi 2005, 34, 288–292.
   Google Scholar
• Heasley LE, Han SY. JNK regulation of oncogenesis. Mol Cells 2006, 21, 167–173.
   Google Scholar
• Laine A, Ronai Z. Ubiquitin chains in the ladder of MAPK signaling. Sci STKE 2005, 281, re5.
   Google Scholar
• Strokin M, Sergeeva M, Reiser G. Docosahexaenoic acid and arachidonic acid release in rat brain astrocytes is mediated by two separate isoforms of phospholipase A2 and is differently regulated by cyclic AMP and Ca2+. Br J Pharmacol 2003, 139, 1014–1022.
   Google Scholar
• Murthy KS, Makhlouf GM. Coexpression of ligand-gated P2X and G proteincoupled P2Y receptors in smooth muscle. Preferential activation of P2Y receptors coupled to phospholipase C (PLC) β1 via Gαq/11 and to PLC-β3 via Gβγi3. J Biol Chem 1998, 273, 4695–4704.
   Google Scholar
• Strassheim D, Williams CL. P2Y2 purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-β isoforms that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. J Biol Chem 2000, 275, 39767–39772.
   Google Scholar
• Gobran LI, Rooney SA. Surfactant secretagogue activation of protein kinase C isoforms in cultured rat type II cells. Am J Physiol 1999, 277, L251–L256.
   Google Scholar
• Hardy AR, Jones ML, Mundell SJ, Poole AW. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood 2004, 104, 1745–1752.
   Google Scholar
• Vial C, Rolf MG, Mahaut-Smith MP, Evans RJ. A study of P2X1 receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. Br J Pharmacol 2002, 135, 363–372.
   Google Scholar
• Czajkowski R, Baranska J. Cross-talk between the ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells. Acta Biochim Pol 2002, 49, 877–889.
   Google Scholar
• Washburn KB, Neary JT. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation. Neuroscience 2006, 142, 411–423.
   Google Scholar
• Soltoff SP, Avraham H, Avraham S, Cantley LC. Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J Biol Chem 1998, 273, 2653–2660.
   Google Scholar
• Kremzinski P, Suplat D, Czajkowski R, Pomorski P, Baranska J. Expression and functional characterization of P2Y1 and P2Y12 nucleotide receptors in long-term serum-deprived glioma C6 cells. FEBS J 2007, 274, 1970–1982.
   Google Scholar
• Hou M, Moller S, Edvinsson L, Erlinge D. Cytokines induce upregulation of vascular P2Y2, receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 2000, 20, 2064–2069.
   Google Scholar
• Wang L, Andersson M, Karlsson L, Watson MA, Cousens DJ, Jern S, Erlinge D. Increased mitogenic and decreased contractile P2 receptors in smooth muscle cells by shear stress in human vessels with intact endothelium. Arterioscler Thromb Vasc Biol 2003, 23, 1370–1376.
   Google Scholar
• Hardy AR, Conley PB, Luo J, Benovic JL, Poole AW, Mundell SJ. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 2005, 105, 3552–3560.
   Google Scholar
• Mundell SJ, Jones ML, Hardy AR, Barton JF, Beaucourt SM, Conley PB, Poole AW. Distinct roles for protein kinase C isoforms in regulating platelet purinergic receptor function. Mol Pharmacol 2006, 70, 1132–1142.
   Google Scholar
• Mundell SJ, Luo J, Benovic JL, Conley PB, Poole AW. Distinct clathrin-coated pits sort different G protein-coupled receptor cargo. Traffic 2006, 7, 1420–1431.
   Google Scholar
• Bhatnagar A, Sheffler DJ, Kroeze WK, Compton-Toth B, Roth BL. Caveolin-1 interacts with 5-HT2A serotonin receptors and profoundly modulates the signaling of selected Galphaq-coupled protein receptors. J Biol Chem 2004, 279, 34614–34623.
   Google Scholar
• Gerevich Z, Zadori Z, Muller C, Wirkner K, Schroder W, P Rubini, P Illes. Metabotropic P2Y receptors inhibit P2X3 receptor-channels via G protein-dependent facilitation of their desensitization. Br J Pharmacol 2007, 151, 226–236.
   Google Scholar
• Xin C, Ren S, Pfeilschifter J, Huwiler A. Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells. Br J Pharmacol 2004, 143, 581–589.
   Google Scholar
• Del Rey A, Renigunta V, Dalpke AH, Leipziger J, Matos JE, Robaye B, Zuzarte M, Kavelaars A, Hanley PJ. Knock-out mice reveal the contributions of P2Y and P2X receptors to nucleotide-induced Ca2+ signaling in macrophages. J Biol Chem 2006, 281, 35147–35155.
   Google Scholar
• Weick M, Wiedemann P, Reichenbach A, Bringmann A. Resensitization of P2Y receptors by growth factor-mediated activation of the phosphatidylinositol-3 kinase in retinal glial cells. Invest Ophthalmol Vis Sci 2005, 46, 1525–1532.
   Google Scholar
• Liu R, Gutierrez AM, Ring A, Persson AE. Nitric oxide induces resensitization of P2Y nucleotide receptors in cultured rat mesangial cells. J Am Soc Nephrol 2002, 13, 313–321.
   Google Scholar
• Tolhurst G, Vial C, Leon C, Gachet C, Evans RJ, Mahaut-Smith MP. Interplay between P2Y1, P2Y12, and P2X1 receptors in the activation of megakaryocyte cation influx currents by ADP, evidence that the primary megakaryocyte represents a fully functional model of platelet P2 receptor signaling. Blood 2005, 106, 1644–1651.
   Google Scholar
• Nakata H, Yoshioka K, Kamiya T, Tsuga H, Oyanagi K. Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 2005, 26, 233–238.
   Google Scholar
• Lakshmi S, Joshi PG. Co-activation of P2Y2 receptor and TRPV channel by ATP: implications for ATP induced pain. Cell Mol Neurobiol 2005, 25, 819–832.
   Google Scholar
• Lee SY, Wolff SC, Nicholas RA, O’Grady SM. P2Y receptors modulate ion channel function through interactions involving the C-terminal domain. Mol Pharmacol 2003, 878–885.
   Google Scholar
• Kaufmann A, Musset B, Limberg SH, Renigunta V, Sus R, Dalpke AH, Heeg KM, Robaye B, Hanley PJ. “Host tissue damage” signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. J Biol Chem 2005, 280, 32459–32467.
   Google Scholar
• Wirkner K, Gunther A, Weber M, Guzman SJ, Krause T, Fuchs J, Köles L, Nörenberg W, Illes P. Modulation of NMDA receptor current in layer V pyramidal neurons of the rat prefrontal cortex by P2Y receptor activation. Cereb Cortex 2007, 17, 621–631.
   Google Scholar
• Ballerini P, Di Iorio P, Ciccarelli R, Caciagli F, Poli A, Beraudi A, Buccella S, D’Alimonte I, D’Auro M, Nargi E, Patricelli P, Visini D, Traversa U. P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia. Int J Immunopathol Pharmacol 2005, 18, 255–268.
   Google Scholar
• Werry TD, Wilkinson GF, Willars GB. Cross talk between P2Y2 nucleotide receptors and CXC chemokine receptor 2 resulting in enhanced Ca2+ signaling involves enhancement of phospholipase C activity and is enabled by incremental Ca2+ release in human embryonic kidney cells. J Pharmacol Exp Ther 2003, 307, 661–669.
   Google Scholar
• Van Kolen K, Gilany K, Moens L, Esmans EL, Slegers H. P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1. Cell Signal 2006, 18, 1169–1181.
   Google Scholar
• Suh BC, Kim JS, Namgung U, Han S, Kim KT. Selective inhibition of β2-adrenergic receptor-mediated cAMP generation by activation of the P2Y2, receptor in mouse pineal gland tumor cells. J Neurochem 2001, 77, 1475–1485.
   Google Scholar